Fragile X syndrome (FXS) is the leading monogenic cause of autism and intellectual disability. FXS is caused by loss of expression of fragile X mental retardation protein (FMRP), an RNA-binding protein that regulates translation of numerous mRNA targets, some of which are present at synapses. While protein synthesis deficits have long been postulated as an etiology of FXS, how FMRP loss affects distributions of newly synthesized proteins is unknown. Here we investigated the role of FMRP in regulating expression of new copies of the synaptic protein PSD95 in an in vitro model of synaptic plasticity. We find that local BDNF application promotes persistent accumulation of new PSD95 at stimulated synapses and dendrites of cultured neurons, and that this accumulation is absent in FMRPdeficient mouse neurons. New PSD95 accumulation at sites of BDNF stimulation does not require known mechanisms regulating FMRP-mRNA interactions but instead requires the PI3K-mTORC1-S6K1 pathway. Surprisingly, in FMRP-deficient neurons, BDNF induction of new PSD95 accumulation can be restored by mTORC1-S6K1 blockade, suggesting that constitutively high mTORC1-S6K1 activity occludes PSD95 regulation by BDNF and that alternative pathways exist to mediate induction when mTORC1-S6K1 is inhibited. This study provides direct evidence for deficits in local protein synthesis and accumulation of newly synthesized protein in response to local stimulation in FXS, and supports mTORC1-S6K1 pathway inhibition as a potential therapeutic approach for FXS.F ragile X syndrome (FXS), the most common monogenic cause of autism and mental retardation, is caused by loss of function of the fragile X mental retardation protein (FMRP) encoded by the Fmr1 gene. FMRP-deficient mice show abnormal spatial learning and social behavior, serving as a model for FXS (1-3). Dendritic spines of FXS patients and of FMRP-deficient mice exhibit abnormal morphology resembling immature spines during neuronal differentiation, suggesting impaired spine maturation (4).Deficits in activity-induced protein synthesis near synapses are likely to contribute to the pathology of FXS. FMRP is an RNAbinding protein localized to dendrites in nucleoprotein particles containing specific mRNAs and ribosome subunits (4). FMRP has roles in both mRNA transport and translational repression, and is required for translational induction of a subset of mRNAs in response to neuronal activity (4, 5). A potential target of FMRP is the mRNA for PSD95, which is the core protein of the postsynaptic density and directly anchors neurotransmitter receptors at the synapse (6). PSD95 protein levels increase in spines that persistently enlarge after long-term potentiation (LTP) but not in spines that only transiently enlarge, suggesting a role for long-term PSD95 accumulation in activity-dependent spine growth (7). FMRP binds to the 3′ untranslated region (UTR) of the PSD95 mRNA, increasing its stability (8) and repressing its translation (9-11). A recent study found that FMRP loss abolished rapid translational ind...